Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by Duediligence33on May 13, 2017 10:57pm
150 Views
Post# 26241628

RE:RE:RE:RE:RE:RE:Valuation

RE:RE:RE:RE:RE:RE:ValuationI like your numbers for next year 
You have 2 premises to base your $ 33  shares price for next year
1. Sales will be 750 million in 2018 so at $ 7.5 / gm = 70,000 kg of product
2. bought deal at $ 6.00 for 40 million shares = $ 240 cash for build out capacity

Question for number 1  if  you need 100,000 sq ft to produce 7,000 kg or
                                        1,000,000 sq ft to produce 70,000 kg  - do we have that NOW ?

Question For number 2 if the bd is done at $ 6.00 this summer will the last bd participants of Dec 2016 at $ 10.60  not be hesitant and maybe want "warrants" (for further dilution) and even if the cash is available immediately after closing how long to build the facility and then to have HC approval (Aph approval for phase 2 still not in after 4 months inspection) and then growing time 
UNLESS they just buy Supreme or Beleave or Maricann or Abcann or Organigram or Cannimed with cash or shares use lie Mettrum.

in any case I agree Weed could be $ 33 next year  based on your premise of 750 million sales  and a BD of 40 million shares $ 6 and 22 % market share with 30 % net margins and we need the capacity of 1 million sq ft to produce 70,000 kg annually.

Wow - $ 6 to $ 33 is a 5 bragger nothing wrong with that over one year.
Hope Queen Nefertiti  is right on I will sign up for that very soon

Bullboard Posts